Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Deafness | frequent | x | x | |
| Nausea | common | x | x | |
| Vertigo | common | x | x | |
| Vomiting | common | x | x | |
| Ototoxicity | common, frequent | x | x | |
| Amblyopia | x | x | ||
| Anaphylactic shock | x | x | ||
| Haemolytic anaemia | x | x | ||
| Angioedema | x | x | ||
| Dermatitis exfoliative | x | x | ||
| Eosinophilia | x | x | ||
| Rash | x | x | ||
| Body temperature increased | x | x | ||
| Leukopenia | x | x | ||
| Pancytopenia | x | x | ||
| Paraesthesia | x | x | ||
| Thrombocytopenia | x | x | ||
| Urticaria | x | x | ||
| Muscular weakness | x | x | ||
| Azotaemia | x | x | ||
| Unable to walk | x | x | ||
| Nephrotoxicity | x | x | ||
| Renal impairment | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |